Our Research
INPT is a patent-pending, breakthrough technology in that there is now no need to catalog or match a person’s infection to an external phage cocktail, a time consuming highly regulated process. New research demonstrates that every human infection enters the body already infected with its own type of phage, in a parasitic/host relationship. Our technology, Induced Native Phage Therapy (INPT) takes control of this relationship regardless the type of infectious agent. Our ongoing research is working to document the ever increasing range of microbes that can be targeted using INPT. The capabilities appear to be endless.
We are the inventor of this technology. What we are doing with native phages has never been done before.
Biospectral Emission Sequencing (BES): The technology that empowers Induced Native Phage Therapy:
We Harness the Power of Phages
Keep up with us!
Sign up for our mailing list or follow us on social media to keep up with all of the latest happenings here at PhagenCorp!
We are committed to earning and maintaining our place at the forefront of medical innovation and excellence by providing constant, continued, and groundbreaking solutions for the abolition of disease.
PhagenCorp
Phage-Biotechnology & Precision Medicine Innovation